AstraZeneca PLC is 56.5x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $5.07 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMRX | AZN |
|---|---|---|
| Market cap | $5.07 B | $286.27 B |
| US-listed rank | #1376 | #45 |
| Revenue (latest FY) | $3.02B | - |
| Net income (latest FY) | $72.06M | - |
| Net margin | 2.4% | - |
| P/E (trailing FY) | 70.3 | - |
| SEC filings | 664 | 1,004 |
AstraZeneca PLC is 56.5x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $5.07 B).
Full pages: Amneal Pharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.